AMARIN CORP PLC\UK
AMRNDrugs in Pipeline
5
Phase 3 Programs
5
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
Get an email about AMRN's next catalysts
Track AMARIN CORP PLC\UK (AMRN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming, 0 past
AMRN Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.28 | FQ end Sep/2026 | Call: tbd
Ethyl-EPA (Miraxion™)
Huntington Disease
AMR101 (ethyl icosapentate)
Hypertriglyceridemia
AMR101
Cardiovascular Diseases
Icosapent ethyl (IPE)
COVID19
Icosapent ethyl
COVID-19
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Ethyl-EPA (Miraxion™) | Phase 3 | Huntington Disease | - | - |
AMR101 (ethyl icosapentate) | Phase 3 | Hypertriglyceridemia | - | - |
AMR101 | Phase 3 | Cardiovascular Diseases | - | - |
Icosapent ethyl (IPE) | Phase 3 | COVID19 | - | - |
Icosapent ethyl | Phase 3 | COVID-19 | - | - |
cardiovascular
1 drug in this indication
Secondary prevention of cardiovascular events
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in AMARIN CORP PLC\UK's drug pipeline?→
CatalystAlert tracks 5 drug candidates in AMARIN CORP PLC\UK's (AMRN) pipeline across Phase 3. Its lead program is AMR101 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is AMARIN CORP PLC\UK's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for AMARIN CORP PLC\UK (AMRN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track AMRN biotech catalysts?→
Add AMRN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow AMARIN CORP PLC\UK's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.